Abstract

Little is known about benefits and risks of acetylcholinesterase inhibitors in patients with advanced dementia, but clinicians and families often are

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call